| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 8 |
| 1 | PEMETREXED | 8 |
| 2 | PEMETREXED DISODIUM | 8 |
| 3 | FUROSEMIDE | 5 |
| 4 | TERIFLUNOMIDE | 5 |
| 5 | GABAPENTIN | 4 |
| 6 | ABATACEPT | 3 |
| 7 | BISOPROLOL FUMARATE | 3 |
| 8 | DIGOXIN | 2 |
| 9 | ERYTHROPOIETIN | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR | 1 | 0.0009 |
| 1 | BARICITINIB | 1 | 0.0003 |
| 2 | PENTOXIFYLLINE | 1 | 0.0002 |
| 3 | PEMETREXED DISODIUM | 8 | 0.0002 |
| 4 | DUTASTERIDE | 1 | 0.0001 |
| 5 | TERIFLUNOMIDE | 5 | 0.0001 |
| 6 | ERYTHROPOIETIN | 2 | 0.0001 |
| 7 | ENTECAVIR | 1 | 0.0001 |
| 8 | CHOLESTYRAMINE | 1 | 0.0001 |
| 9 | PEMBROLIZUMAB | 8 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 1 | Pyrimidine Synthesis Inhibitor [EPC] | 5 | 0.0001 |
| 2 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 8 | 0.0001 |
| 4 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 5 | Cardiac Glycoside [EPC] | 2 | 0.0000 |
| 6 | Selective T Cell Costimulation Modulator [EPC] | 3 | 0.0000 |
| 7 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 1 | 0.0000 |